Medical progress: Dialysis therapy

New England Journal of Medicine

Volumn 338, Issue 20, 1998, Pages 1428-1437

  Pastan, Stephen ^a,b   Bailey, James ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST; DIALYSATE; DIALYSIS; DIALYSIS MEMBRANE; HEALTH CARE QUALITY; HUMAN; HYPOTENSION; KIDNEY FAILURE; LIFE EXPECTANCY; MORTALITY; PERITONEAL DIALYSIS; PRIORITY JOURNAL; REVIEW; SURVIVAL; ARTIFICIAL MEMBRANE; CHRONIC KIDNEY FAILURE; HEALTH CARE COST; INSTRUMENTATION; METHODOLOGY; PERITONITIS; RECYCLING; RENAL REPLACEMENT THERAPY; SURVIVAL RATE;

HEMODIALYSIS FLUID;

EQUIPMENT REUSE; HEALTH CARE COSTS; HEMODIALYSIS SOLUTIONS; HUMANS; KIDNEY FAILURE, CHRONIC; MEMBRANES, ARTIFICIAL; PERITONEAL DIALYSIS; PERITONITIS; RENAL DIALYSIS; SURVIVAL RATE;

EID: 0032516130     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199805143382006     Document Type: Review

References (86)

1. Renal Data System. USRDS 1997 annual data report. Bethesda, Md.: National Institute of Diabetes and Digestive and Kidney Diseases, 1997.
2. Ad Hoc Committee on Nephrology Manpower Needs. Estimating workforce and training requirements for nephrologists through the year 2010. J Am Soc Nephrol 1997;8:Suppl 9:1-32.
3. Winston JA, Klotman PE. Are we missing an epidemic of HIV-associated nephropathy? J Am Soc Nephrol 1996;7:1-7
4. D'Agati V, Appel GB. HIV infection and the kidney. J Am Soc Nephrol 1997;8:138-52.
5. Renal Data System. USRDS 1995 annual data report. Bethesda, Md.: National Institute of Diabetes and Digestive and Kidney Diseases, 1995.
6. Diamond SM, Henrich WL. Acetate dialysate versus bicarbonate dialysate: a continuing controversy. Am J Kidney Dis 1987;9:3-11.
7. Feig PU, Shook A, Sterns RH. Effect of potassium removal during hemodialysis on the plasma potassium concentration. Nephron 1981;27:25-30.
8. Henrich WL, Hunt JM, Nixon JV. Increased ionized calcium and left ventricular contractility during hemodialysis. N Engl J Med 1984;310:19-23.
9. Slatopolsky E, Weerts C, Lopez-Hilker S, et al. Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis. N Engl J Med 1986;315:157-61.
10. Indridason OS, Quarles LD. Oral versus intravenous calcitriol: is the route of administration really important? Curr Opin Nephrol Hypertens 1995;4:307-12.
11. Henrich WL, Woodard TD, McPhaul JJ Jr. The chronic efficacy and safety of high sodium dialysate: double-blind, crossover study. Am J Kidney Dis 1982;2:349-53.
12. Van Stone JC, Bauer J, Carey J. The effect of dialysate sodium concentration on body fluid distribution during hemodialysis. Trans Am Soc Artif Intern Organs 1980;26:383-6.
13. Levin A, Goldstein MB. The benefits and side effects of ramped hypertonic sodium dialysis. J Am Soc Nephrol 1996;7:242-6.
14. Flanigan MJ, Khairullah QT, Lim VS. Dialysate sodium delivery can alter chronic blood pressure management. Am J Kidney Dis 1997;29:383-91.
15. Daugirdas JT, Al-Kudsi RR, Ing TS, Norusis MJ. A double-blind evaluation of sodium gradient hemodialysis. Am J Nephrol 1985;5:163-8.
16. Sang GLS, Kovithavongs C, Ulan R, Kjellstrand CM. Sodium ramping in hemodialysis: a study of beneficial and adverse effect. Am J Kidney Dis 1997;29:669-77.
17. Rosborough DC, Van Stone JC. Dialysate glucose. Semin Dial 1993; 6:260-3.
18. Ismail N, Becker BN, Hakim RM. Water treatment for hemodialysis. Am J Nephrol 1996;16:60-72.
19. Tokars JI, Alter MJ, Miller E, Moyer LA, Favero MS. National surveillance of dialysis associated diseases in the United States - 1994. ASAIO J 1997;43:108-19.
20. Converse RL Jr, Jacobsen TN, Jost CM, et al. Paradoxical withdrawal of reflex vasoconstriction as a cause of hemodialysis-induced hypotension. J Clin Invest 1992;90:1657-65.
21. Jost CM, Agarwal R, Khair-el-Din T, Grayburn PA, Victor RG, Henrich WL. Effects of cooler temperature dialysate on hemodynamic stability in "problem" dialysis patients. Kidney Int 1993;44:606-12.
22. Abuelo JG, Shemin D, Chazan JA. Acute symptoms produced by hemodialysis: a review of their causes and associations. Semin Dial 1993;6: 59-69.
23. Hakim RM, Breillatt J, Lazarus JM, Port FK. Complement activation and hypersensitivity reactions to dialysis membranes. N Engl J Med 1984; 311:878-82.
24. Verresen L, Fink E, Lemke HD, Vanrenterghem Y. Bradykinin is a mediator of anaphylactoid reactions during hemodialysis with AN69 membranes. Kidney Int 1994;45:1497-503.
25. Pegues DA, Beck-Sague CM, Woollen SW, et al. Anaphylactoid reactions associated with reuse of hollow-fiber hemodialyzers and ACE inhibitors. Kidney Int 1992;42:1232-7.
26. Bregman H, Daugirdas JT, Ing TS. Complications during hemodialysis. In: Daugirdas JT, Ing TS, eds. Handbook of dialysis. 2nd ed. Boston: Little, Brown, 1994:149-68.
27. Radovich JM. Composition of polymer membranes for therapies of end-stage renal disease. In: Bonomini V, Berland Y, eds. Dialysis membranes: structure and predictions. Basel, Switzerland: Karger, 1995:11-24.
28. Churchill DN. Efficiency and biocompatibility of membranes. In: Bonomini V, Berland Y, eds. Dialysis membranes: structure and predictions. Basel, Switzerland: Karger, 1995:60-71.
29. Pascual M, Tolkoff-Rubin N, Schifferli JA. Is adsorption an important characteristic of dialysis membranes? Kidney Int 1996;49:309-13.
30. Stivelman JC, Soucie JM, Hall ES, Macon EJ. Dialysis survival in a large inner-city facility: a comparison to national rates. J Am Soc Nephrol 1995;6:1256-61.
31. Dumler F, Stalla K, Mohini R, Zasuwa G, Levin NW. Clinical experience with short-time hemodialysis. Am J Kidney Dis 1992;19:49-56.
32. Hakim RM. Clinical implications of hemodialysis membrane biocompatibility. Kidney Int 1993;44:484-94.
33. Hakim RM, Held PJ, Stannard DC, et al. Effect of the dialysis membrane on mortality of chronic hemodialysis patients. Kidney Int 1996;50: 566-70.
34. Lazarus JM, Owen WF. Role of bioincompatibility in dialysis morbidity and mortality. Am J Kidney Dis 1994;24:1019-32.
35. Hakim RM, Wingard RL, Parker RA. Effect of the dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med 1994; 331:1338-42.
36. Himmelfarb J, Tolkoff Rubin N, Chandran P, Parker RA, Wingard RL, Hakim R. A multicenter comparison of dialysis membranes in the treatment of acute renal failure requiring dialysis. J Am Soc Nephrol 1998;9: 257-66.
37. Jacobs C. Membrane biocompatibility in the treatment of acute renal failure: what is the evidence in 1996? Nephrol Dial Transplant 1997;12:38-42.
38. Feldman HI, Kinosian M, Bilker WB, et al. Effect of dialyzer reuse on survival of patients treated with hemodialysis. JAMA 1996;276:620-5.
39. Wing AJ, Brunner FP, Brynger HO, et al. Mortality and morbidity of reusing dialyzers: a report by the registration committee of the European Dialysis and Transplant Association. BMJ 1978;2:853-5.
40. Pollak VE, Kant KS, Parnell SL, Levin NW. Repeated use of dialyzers is safe: long-term observations on morbidity and mortality in patients with end-stage renal disease. Nephron 1986;42:217-23.
41. Held PJ, Pauly MV, Diamond L. Survival analysis of patients undergoing dialysis. JAMA 1987;257:645-50.
42. Task Force on Reuse of Dialyzers, Council on Dialysis, National Kidney Foundation. National Kidney Foundation report on dialyzer reuse. Am J Kidney Dis 1997;30:859-71.
43. Rocco MV, Bleyer AJ, Burkart JM. Utilization of inpatient and outpatient resources for the management of hemodialysis access complications. Am J Kidney Dis 1996;28:250-6.
44. Feldman HI, Kobrin S, Wasserstein A. Hemodialysis vascular access morbidity. J Am Soc Nephrol 1996;7:523-35.
45. Besarab A, Frinak S, Zasuwa G. Prospective evaluation of vascular access function: the nephrologist's perspective. Semin Dial 1996;9:Suppl 1: S-21-S-29.
46. Sukhatme VP. Vascular access stenosis: prospects for prevention and therapy. Kidney Int 1996;49:1161-74.
47. Cimochowski GE, Worley E, Rutherford WE, Sartain J, Blondin J, Harter H. Superiority of the internal jugular over the subclavian access for temporary dialysis. Nephron 1990;54:154-61.
48. McLaughlin K, Jones B, Mactier R, Porteus C. Long-term vascular access for hemodialysis using silicon dual-lumen catheters with guidewire replacement of catheters for technique salvage. Am J Kidney Dis 1997;29: 553-9.
49. Depner TA. Prescribing hemodialysis: a guide to urea modeling. Boston: Kluwer Academic, 1991.
50. Gotch FA, Sargent JA. A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 1985;28:526-34.
51. Owen WF Jr, Lew NL, Liu Y, Lowrie EG, Lazarus JM. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993;329:1001-6.
52. Held PJ, Port FK, Wolfe RA, et al. The dose of hemodialysis and patient mortality. Kidney Int 1996;50:550-6.
53. Eknoyan G, Levey AS, Beck GJ, et al. The hemodialysis (HEMO) study: rationale for selection of interventions. Semin Dial 1996;9:24-33.
54. Lowrie EG, Laird NM, eds. Cooperative dialysis study. Kidney Int 1983;23:Suppl 13:S-1-S-122.
55. Held PJ, Levin NW, Bovbjerg RR, Pauly MV, Diamond LH. Mortality and duration of hemodialysis treatment. JAMA 1991;265:871-5.
56. Charra B, Calemard E, Ruffet M, et al. Survival as an index of adequacy of dialysis. Kidney Int 1992;41:1286-91.
57. Charra B, Calemard E, Laurent G. Importance of treatment time and blood pressure control in achieving long-term survival on dialysis. Am J Nephrol 1996;16:35-44.
58. 1996 Annual report: ESRD Core Indicators Project: opportunities to improve care for adult in-center hemodialysis patients. Baltimore: Health Care Financing Administration, 1997:35-7.
59. Mann JFE. Hypertension and cardiovascular effects - long-term safety and potential long-term benefits of r-HuEPO. Nephrol Dial Transplant 1995;10:Suppl 2:80-4.
60. Radermacher J, Koch KM. Treatment of renal anemia by erythropoietin substitution: the effects on the cardiovascular system. Clin Nephrol 1995;44:Suppl 1:S-56-S-60.
61. Ikizler TA, Hakim RM. Nutrition in end-stage renal disease. Kidney Int 1996;50:343-57.
62. Chertow GM, Lazarus JM. Malnutrition as a risk factor for morbidity and mortality in maintenance dialysis patients. In: Kopple JD, Massry SG, eds, Nutritional management of renal disease. Baltimore: Williams & Wilkins, 1997:257-76.
63. Ahmed KR, Kopple JD. Nutrition in maintenance hemodialysis patients. In: Kopple JD, Massry SG, eds. Nutritional management of renal disease. Baltimore: Williams & Wilkins, 1997:563-600.
64. Friedman EA. End-stage renal disease therapy: an American success story. JAMA 1996;275:1118-22.
65. 1997 Annual report: ESRD Core Indicators Project: opportunities to improve care for adult in-center hemodialysis and peritoneal dialysis patients. Baltimore: Health Care Financing Administration, 1997:19-28.
66. Marwick C. New campaign aims to cut dialysis patient deaths. JAMA 1995;273:10-1.
67. Clinical practice guidelines: hemodialysis adequacy: peritoneal dialysis adequacy. Am J Kidney Dis 1997;30:Suppl 2:S1-S136.
68. Clinical practice guidelines: vascular access: anemia of chronic renal failure. Am J Kidney Dis 1997;30:Suppl 3:S137-S240.
69. Nolph KD. Peritoneal dialysis. In: Gonick HC, ed. Current nephrology. Vol. 19. St. Louis: Mosby-Year Book, 1996:281-2.
70. Lysaght MJ, Pollock CA, Hallet MD, Ibels LS, Farrell PC. The relevance of urea kinetic modeling to CAPD. ASAIO Trans 1989;35:784-90.
71. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 1996;7:198-207
72. Nolph KD, Jensen RA, Khanna R, Twardowski ZJ. Weight limitations for weekly urea clearances using various exchange volumes in continuous ambulatory peritoneal dialysis. Perit Dial Int 1994;14:261-4.
73. Twardowski ZJ, Nolph KD, Khanna R, et al. Peritoneal equilibration test. Perit Dial Bull 1987;7:138-47.
74. Rodby RA, Vonesh EF, Korbet SM. Blood pressures in hemodialysis and peritoneal dialysis using ambulatory blood pressure monitoring. Am J Kidney Dis 1994;23:401-11.
75. Viglino G, Colombo A, Scalamogna A, et al. Prospected randomized study of two Y devices in continuous ambulatory peritoneal dialysis (CAPD). Perit Dial Int 1989;9:165-8.
76. Bloembergen WE, Port FK. Epidemiological perspective on infections in chronic dialysis patients. Adv Ren Replace Ther 1996;3:201-7.
77. Farias MG, Soucie JM, McClellan W, Mitch WE. Race and the risk of peritonitis: an analysis of factors associated with the initial episode. Kidney Int 1994;46:1392-6.
78. Keane WF, Alexander SR, Bailie GR, et al. Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update. Perit Dial Int 1996; 16:557-73.
79. Selgas R, Munoz J, Cigarran S, et al. Peritoneal functional parameters after five years on continuous ambulatory peritoneal dialysis (CAPD): the effect of late peritonitis. Perit Dial Int 1989;9:329-32.
80. Goldie SJ, Kiernan-Tridle L, Torres C, et al. Fungal peritonitis in a large chronic peritoneal dialysis population: a report of 55 episodes. Am J Kidney Dis 1996;28:86-91.
81. Twardowski ZJ, ed. Peritoneal catheter exit-site morphology and pathology: prevention, diagnosis, and treatment of exit site infections. Perit Dial Int 1996;16:Suppl 3:S1-S117.
82. Wanten GJ, van Oost P, Schneeberger PM, Koolen MI. Nasal carriage and peritonitis by Staphylococcus aureus in patients on continuous ambulatory peritoneal dialysis: a prospective study. Perit Dial Int 1996;16:352-6.
83. Bergstrom J, Furst P, Alvestrand A, Lindholm B. Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis. Kidney Int 1993;44:1048-57.
84. Scarpioni L, Ballocchi S, Scarpioni R, Cristinelli L. Peritoneal dialysis in diabetics, optimal insulin therapy on CAPD: intraperitoneal versus subcutaneous treatment. Perit Dial Int 1996;16:Suppl 1:S275-S278.
85. Held PJ, Port FK, Turenne MN, Gaylin DS, Hamburger RJ, Wolfe RA. Continuous ambulatory peritoneal dialysis and hemodialysis: comparison of patient mortality with adjustment for comorbid conditions. Kidney Int 1994;45:1163-9.
86. Bloembergen WE, Port FK, Mauger EA, Wolfe RA. A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 1995;6:177-83.